The rapid progress in nutritional epigenetics allowed for a much better understanding of the mechanisms involved in gene-nutrient interactions and the roles that nutrition has in transgenerational inheritance of acquired epigenetic traits. Studies indicated that a considerable number of nutrients or diet types are capable of inducing epimutations. In parallel, the rapid development of genome-wide DNA methylation detection methods allowed for a broader image on how nutrition impacts the epigenetic status in human and animal models. But this increased complexity in the epigenetic fi eld and also brought important challenges that need resolution, or it suggests that some of the initial epigenetic paradigms have to be revisited or reconsidered. The aim of this review is to discuss the inherent challenges that need to be resolved, from both practical and theoretical aspects, stemming from the rapid progress in the fi eld of nutritional epigenetics, with a focus on DNA methylation. Because such challenges are present at every stage of study development, the review systematically discusses the most common issues relevant to DNA methylation in a nutritional context. Various types of challenges and potential bias generators are discussed within study design, sample quality, detection methods, data processing, and statistical and bioinformatic analysis. Additional aspects to be considered include epigenetic heterogeneity of treatment groups, the role of genomic variability in introducing measurement bias and errors in interpretation of changes, and issues related to the fi nal interpretation of results and in assigning functional signifi cance. It is also posited that all these issues will be largely resolved within the next decade.
Introduction
During the last two decades, signifi cant progress has been made in unraveling the molecular mechanisms responsible for gene-environment interactions. Concurrently, nutrition was identifi ed as a strong player that can alter developmental plasticity and that, by consequence, can infl uence both early and late health outcomes including brain development, cognition, aging, cancer, and the development of chronic conditions, such as obesity and associated metabolic diseases (1) .
Epigenetic mechanisms are molecular events, other than changes in DNA sequence, which establish meiotically and mitotically stable, heritable patterns of gene expression (2, 3) . These include DNA methylation and hydroxymethylation, histone modifi cations, along with the modulation of epigenetic marks by noncoding RNA (3 -5) .
Validating and using suitable experimental and epidemiological models for nutritional epigenetics is essential for successful research on transgenerational inheritance and in establishing the role of nutrition in the epigenetic regulation of gene expression (4) . The considerable focus, dedicated by researchers to understanding the epigenetic events associated with gene-nutrient interactions, led to an impressive array of studies describing the complex interactions between nutrients and the epigenetic machinery (6 -8) . This impressive progress not only has allowed better understanding of how nutrients alter our epigenomes but also has indicated that, in many cases, some of the old paradigms should be either revised or more accurately interpreted. Moreover, the accelerated development of high-throughput platforms pointed out to many questions still to be answered, regarding the experimental design, statistical analysis and bioinformatic approaches, and how they could potentially bias not only the fi nal results but also the functional interpretation of data (9 -11) .
This review discusses the challenges to be considered when nutritional studies are designed to include DNA methylation components.
Brief introduction to epigenetic mechanisms

DNA methylation
DNA methylation consists of the covalent substitution of hydrogen with methyl groups to DNA [reviewed in (12) ]. In eukaryotes, DNA methylation occurs mainly at the 5 position of the cytosine ring [5-methylcytosine (5mC) ], only when it is followed by a guanine nucleotide (CpG sites), although methyl groups can also be added to other nucleotides (12) . This reaction is catalyzed by DNA methyltransferases (DNMTs). During the S-phase of cell cycle, the DNA methylation pattern of the parental DNA strand is duplicated on the newly synthesized DNA [maintenance DNA methylation catalyzed by DNMT1, discussed in (13) ].
The methylation process can also occur at previously unmethylated CpG sites ( de novo DNA methylation), catalyzed by DNMT3a and 3b, and with participation of DNMT2 and 3L (13) .
DNA methylation within promoter regions usually is associated with gene underexpression and chromatin compaction ( Figure 1 ) (14) , but instances were described when promoter hypermethylation prevented the binding of inhibitory factors allowing overexpression (15) . The establishment of specifi c DNA methylation patterns contributes decisively to shaping specifi c and stable cellular phenotypes of differentiated cells (13) .
An important epigenetic feature is genomic imprinting, which allows genes to be expressed in a parent-of-origin manner (imprinted genes, the molecular basis for monoallelic expression) (16) . This monoallelic expression is the consequence of parent-specifi c DNA methylation patterns that are generally maintained throughout embryonic and fetal development in the somatic cells (17) . Presently, more than 100 genes have been identifi ed in humans and mice, although notable differences exist between mammalian species (18) . During early embryogenesis, with the exception of imprinted genes, the parental DNA methylation patterns are erased by active and passive demethylation mechanisms (with the exception of some imprinted regions), and new patterns are established by de novo methylation (Figure 1 ) process that continues during fetal morphogenesis and even in early postnatal period (19) .
The epigenetics of DNA is not only confi ned to DNA methylation but also to the hydroxylation of the methyl groups attached to cytosine, with important functional consequences upon gene activation (Figure 1 ) (20) . This recent groundbreaking discovery provided the fi rst plausible mechanism for Figure 1 Schematic relationship between nutrition, promoter DNA methylation and demethylation, and consequences upon gene expression. Nutrition can alter gene-specifi c DNA methylation. When these alterations occur at promoter sequences, there is an inverse relationship between the degree of DNA methylation and gene expression. In some instances recently described, active DNA demethylation occurs via hydroxylation of the methyl group attached to the cytosine ring, process catalyzed by ten-eleven-translocation (TET) enzymes. the previously described active DNA demethylation (5) and could explain the DNA methylation fi delity (21) .
Histone modifi cations
Chromatin modifi cations occur at the fl exible tail regions of histones. Such modifi cations include, but are not limited to, methylation, acetylation, phosphorylation, ubiquitination, and ADP ribosylation (22) . In correlation with DNA methylation, histone modifi cations allow for the reversible switch between chromatin compaction and relaxation and, therefore, establishing the degree of access for transcription factors to promoter regions (13, 22) . A few examples are methylation of histone H3 at its lysine 9 and 27 residues (K9 and K27), allowing for chromatin compaction and inhibition of gene expression, while trimethylation of H3K4 induces transcriptional activation (22) .
Debate still exists on whether these epigenetic changes can be inherited during cell division or if there is instead a de novo re-establishment of the histone epigenetic status in daughter cells (23) .
Noncoding RNA
MicroRNAs (miRNAs) are noncoding RNA species, up to 25 nucleotides in length, which contribute to gene expression regulation through RNA interference (RNAi) (24) . miRNAs modulate the expression of several genes involved in the epigenetic machinery responsible for DNA and histone modifi cations (a few examples are DNMT3a/b , HDAC1/4 , and MeCP2 ) (24) . Some miRNAs can also be epigenetically regulated, their gene expression being highly dependent on their promoter methylation [reviewed in (24) ]. Exogenous small-interfering RNA (siRNA), when targeted to a promoter region, can also induce DNA hypermethylation and increased dimethylation of H3K9 (H3K9me2) (25) .
Gene-nutrient interactions and DNA methylation
Many nutrients and several types of diet have been shown to alter the epigenetic status in animals or humans. Consistently, it has been indicated that the epigenetic impact of nutrients can be specifi c to a certain development period, embryogenesis and fetal periods being the most vulnerable windows for epigenetic alterations, followed by early postnatal period (26) . Other studies have indicated that nutrient intakes in one generation can alter the epigenetic status in offspring and subsequent generations, with possible consequences upon their aging processes [reviewed in (4) ]. Nutrients, such as folate, choline, niacin, fl avonoids, or selenium are but a few examples (4) . Table 1 indicates a selected list of studies, which highlighted the causal role or observed correlation of nutrition in the alteration of DNA methylation in various models.
The epigenetic roles of choline, betaine, and methionine have been studied mostly in the context of fetal development. Similar to folate, choline and its metabolite betaine act in concert for establishing the pool of S-adenosylmethionine (SAM) required for various methylation reactions, including DNA methylation (45) . As discussed in a recent review, most of the studies using choline focused on its roles in brain development and function and liver function (46) . As indicated in Table 1 , maternal choline availability induced genespecifi c DNA methylation changes in fetal brain and liver, including promoter hypomethylation of Cdkn3 and Dnmt1 , and promoter hypermethylation of Calb1 , Igf2 , G9a , and Suv39h1 (15, 30 -32) . In the mouse liver, betaine supplementation altered both histone and DNA methylation in FAT10-positive cells (33) . A diet low in methionine, choline, and folic acid induced CpG island hypermethylation (similar to those associated with a cancer phenotype) in adult rat livers (47) . The mechanisms by which folate, methionine, choline, and betaine dietary availability alter the epigenetic profi le are not clearly understood. Initially, it was considered that the primary mechanism responsible for epigenetic changes is directly related to the available amount of methyl groups from SAM (14) . However, two recent studies indicated (as other previous reports also suggested) that, while SAM concentrations are stable, gene-specifi c epigenetic mechanisms could be involved rather than simply SAM availability for methylation reactions (48, 49) .
The constant increase of the obesity epidemic, especially in children, has become a major area of research for nutritional epigenetics. Epidemiological studies indicated that food availability is not only important for the nutritional status of the directly exposed generation but also for their children. Data collected using the Dutch famine cohort revealed that maternal food restriction during pregnancy altered the DNA methylation of genes in the subsequent generation and that some of these genes are involved in the pathogenesis of obesity and diabetes (leptin and IGF2 ) (50) . In a very recent study, higher adiposity in prepubertal children was associated with increased promoter methylation of the retinoid X receptor-α ( RXRA ) in umbilical cord, as a result of lower maternal carbohydrate intake in early pregnancy (41) . Animal studies indicated that, by altering the macronutrient availability in maternal diets, global and gene-specifi c DNA methylation patters can be modifi ed in the offspring. As indicated in Table  1 , a high-fat obesogenic diet induced leptin hypermethylation and Cdkn1 a hypomethylation in rats, while global nutrient restriction was associated with sex-specifi c changes in DNA methylation (34 -37) . Maternal protein restriction also infl uenced the DNA methylation status of genes involved not only in obesity and diabetes pathogenesis (leptin and IGF2/H19 ) RGC1 , reduced folate carrier; IGF2 (Igf2) , insulin-like growth factor 2; DMR, differentially methylated region; Ppar α , peroxisome proliferator-activated receptor-α; GR , glucocorticoid receptor; IR , insulin receptor; Cdkn3 , cyclin-dependent kinase inhibitor 3; Calb1 , calbindin 1; G9a , histone-lysine N-methyltransferase 2; Suv39h1 , suppressor of variegation 3 -9 homolog 1; Dnmt1 , DNA methyl-transferase 1; SAM, S-adenosylmethionine; Cdkn1a , cyclin-dependent kinase inhibitor 1a; ICR, imprinting control region; H19 , H19 imprinted maternally expressed transcript (nonprotein coding); Dnmt3a , DNA methyl-transferase 3a; Mbd2 , methyl-CpG-binding domain protein 2; RXRA, retinoid X receptor-α ; VHL, von Hippel-Lindau tumor suppressor; A vy IAP, viable yellow intracisternal A particle.
but also in the DNA methylation machinery ( Dnmt1 , Dnmt3a , and Mbd2 ) (38 -40) . These few examples point toward the importance of nutrition in shaping the epigenetic status in various experimental models and to the potentially causal association between DNA methylation alterations and functional consequences (as brain development, obesity, diabetes, and cancer).
Challenging aspects
The unprecedented progress in nutritional epigenetics not only allowed for an equally deep understanding of the roles played by DNA methylation in mediating gene-nutrient interactions but also brought the need for developing sensitive, accurate, and complex detection platforms. Fortunately, the fi eld of epigenetics benefi ted from the methods developed earlier in the fi eld of genetics and genomics.
The accelerated pace of epigenetic discoveries also brought multiple challenges, in many aspects, and at many levels. From the stage of designing a study and formulating a hypothesis, and ending with the fi nal data processing and interpretation, these challenges exist at virtually every step down the road. Table 2 summarizes many examples of the unknowns and the diffi culties encountered in properly assessing DNA methylation outcomes and interpretation of data, in the context of nutritional studies, as discussed below. While discussing these aspects, the studies cited will serve only as examples of the complex intricacies encountered. The discussion of these examples is not meant to diminish, by any measure, the extraordinary importance of the discussed work.
Study design
Challenges encountered in study design concern at least three elements: the optimal time of exposure, the composition of Table 2 Summary of challenges, potential biases, and possible solutions in nutrition-related DNA methylation studies.
Component
Variables Challenges/potential bias/possible solutions Study design DNA methylation is time (age) dependent.
Dietary composition (macronutrient replacement for defi ned diets). Is the animal model relevant to humans ?
Consider the developmental periods for establishment of DNA methylation patters (these are organ specifi c). Consider the length of exposure. For induced nutrient defi ciency, consider whether a depletion period is necessary. Diffi cult to assign epigenetic changes to either the replacing (supplemented) or the replaced (defi cient) macronutrient (e.g., saturated fat replacing the starch in an obesogenic diet).
Chromosome location may differ → potential for different mechanisms in regulating DNA methylation, especially for clustered genes. Parental imprinting may differ between species.
Epigenetic heterogeneity
Isogenic animals may have different epigenetic status at baseline (study start).
False negatives present due to nonhomogenous response (responders vs. nonresponders or the extent of changes varies greatly). Need to assess the type of response and defi ne markers with predictive value for the response to exposure. See also statistical distribution below.
Genomic variability
SNPs at CpG sites
Other types of mutations (deletions/insertions) CNVs
Detection bias (especially for methods based on pyrosequencing and methylation-sensitive restriction). Genotyping is required in parallel. Detection bias for all methods. Genomic sequencing is required in parallel.
Potential bias in interpreting the detected changes in DNA methylation. Is the methylation status the same in all copies ? Also, methylation-sensitive restriction and chromatin precipitation is affected (overestimation of the nonrestricted/recovered strands when normalized to the same amount of total genomic DNA).
Sample
Tissue heterogeneity Detected changes in DNA methylation can be merely the expression of a change in the distribution of cell types within the tissue → false changes (e.g., changes in the distribution of lymphocyte subclasses as component of an immune response). Cell sorting required.
Detection Presence of 5hmC
DNA processing
Pyrosequencing and methylation-sensitive restriction enzymes do not distinguish between the methylated and hydroxymethylated cytosine. Specifi c bias for different types of DNA processing and detection (chromatin immunoprecipitation vs. pyrosequencing vs. restriction-based methods).
Data processing Specifi c to microarray platforms
Assumption of normal distribution is not necessarily true → bias in applying the proper statistical tests. Normalization issues.
Statistical analysis
All methods β -distribution. Use dedicated methods (e.g., clustering and partitioning).
Bioinformatics
Epigenomic studies Standardization of computational methods is needed.
Data interpretation
All methods Signifi cance of epigenetic alterations in proxy tissues. Controlling for age-dependent epi genetic alterations.
Please refer to the section " Challenging aspects " for a detailed description.
diets, and, in the case of animal models, the relevancy of these models to the epigenetic milieu in humans. Because the gestation and early postnatal life are the most active periods for the re-establishment of DNA methylation patters, most of the studies focused on early epigenetic effects of maternal diets upon perinatal development and the consequences upon later metabolic diseases (4, 51) . In contrast, because the epigenetic processes associated with adult life and aging are less known, we have a limited understanding of the role played by nutrition in modifying the epigenome in later life stages (4) . Therefore, adequate timing of the nutritional intervention is essential for a successful study design (52) . Dietary experiments involving macronutrient replacement/ addition/subtraction are another challenging aspect regarding the functional interpretation of epigenetic outcomes. In studies using isocaloric diets, in which macronutrient replacement is used [e.g., protein restriction as in (38) ], it is inevitable that the change in the composition of a macronutrient to be associated with an opposite change of one or other several nutrients. By consequence, an inherent feature of such studies is that a causal relationship between epigenetic changes and the availability of a macronutrient class (whether protein, fat, or hydrocarbonates) cannot be established with certainty. It is entirely possible that the observed epigenetic outcomes to be related either to the defi cient component or to the added nutrients.
A third element is the relevance of animal models in unraveling the epigenetic mechanisms that are pertinent to humans. There is no doubt that animal models have provided the means for characterizing most of the epigenetic mechanisms involved in gene-nutrient interactions, allowing for breakthrough discoveries that, ultimately, helped us in understanding the human epigenetic processes. However, a critical approach has to be considered when trying to translate these discoveries to human models. An example of a breakthrough discovery in animal models is the use of the agouti mouse model to unravel the epigenetic roles of methyl donors (folate, methionine, choline, and betaine), genistein, and Bisphenol A (BPA) (44, 53) . In this case, the initial fi nding of DNA methylation alterations induced within the viable yellow intracisternal A particle ( A vy IAP) provided, for the fi rst time, the proof of concept that epigenetic marks can be robust sensors that correlate with the phenotypic changes induced by environmental factors. However, in humans, it is very diffi cult to prove that similar epimutations are inherited because genetic causes cannot be excluded [discussed in (54) ]. As humans have approximately 10-fold fewer IAP transposons than mice (55) , it is still a matter of debate how relevant such described changes are to human epigenetic regulation of gene expression.
Epigenetic heterogeneity of isogenic animals is another element to consider. Using the same example as above (the agouti model), it has been indicated that DNA methylation within metastable epialleles is a stochastic process (56) . In rodent models, this variation in the DNA methylation during embryogenesis would bring heterogeneity in the epigenetic patterns in pups from the same litter, as well as in pups from different dams. Therefore, the assumption that isogenic animals can be safely used for nutritional epigenetic studies (having the same epigenetic background) may not be necessary true in all instances. As a consequence, there could be a signifi cant bias in the epigenetic response to a nutrition intervention due to such different epigenetic backgrounds, with important consequences in data distribution and statistical power.
Genomic variability is another strong confounder in nutritional epigenetics, which applies mostly to human studies. Two types of errors can occur at this level: detection and interpretation bias. The presence of single nucleotide polymorphisms (SNPs) and insertions/deletions encompassing CpG sites would lead to detection bias when using either pyrosequencing or methylation-sensitive detection methods (9) . The presence of such variations in the proximity of CpG sites would lead to detection errors concerning mainly pyrosequencing (potential PCR amplifi cation bias as well as errors at the dispensation/polymerization fi nal stage).
The presence of copy number variations (CNVs) within the human genome has been amply documented and seems to be more abundant than point mutations (57) . Presently, little is known about the epigenetic status of CNVs compared to the original alleles, and considerable limitations in detecting such differences exist for most methods, especially for microarray-based methods and pyrosequencing (58) . Moreover, the interpretation of changes in DNA methylation for genes with multiple copies is very diffi cult, false positives being possible merely due to differences in the amount of template, when normalized to total genomic DNA. One approach is the study of epigenetic variation in identical twins exposed to different environments (59) . However, the assumption that identical twins are isogenic has been recently challenged by Bruder and colleagues who reported the existence of discordant CNV profi les between monozygotic twins (60) .
Tissue heterogeneity can also introduce errors in interpreting DNA methylation changes. Most of the nutritional studies reporting epigenetic outcomes have used, and are still using, DNA extracted from tissues, which contain a variety of cell types. As each cellular phenotype is highly dependent upon its epigenetic profi le, DNA methylation values obtained from a tissue represents the weighted average value across all cell types. A telling example is the use of blood DNA. Many nutritional studies use DNA from whole blood to assess the extent of epigenetic changes induced by dietary cues. However, as several papers indicated, the DNA methylation profi les of mononucleate cells, and especially of lymphocyte subtypes, can be dramatically different for a given gene (61) . It is conceivable that a certain dietary treatment (e.g., an obesogenic diet) will induce infl ammatory changes (within the induced metabolic syndrome) that would skew the distribution of certain types of lymphocytes implicated in the infl ammatory response. Therefore, in such an example, the changes in DNA methylation within whole blood DNA may represent merely a change in cellular distribution and be falsely assumed as veritable epigenetic alterations. The obvious solution is the characterization of epigenetic profi les for each cell type (or selected types) within the tissue, which is a costly and timeconsuming process.
Detection specifi city and sensitivity are features that have to be carefully addressed both at study design and in data interpretation. The multitude of detection methods, discussed elsewhere (62) , comes with specifi c advantages and also with inherent limitations (9, 62) . The breakthrough discovery of the functional role of hydroxymethylation came also with a new challenge regarding not only the detection of 5-hydroxymethylcytosine (5hmC), but also with an interesting question regarding previous studies. How many of these previous DNA methylation studies did correctly report changes in 5mC content without inadvertently incorporating undetected changes in 5hmC ? This question is important in the context of the different functional signifi cance for gene expression between 5mC and 5hmC, as discussed elsewhere (20, 21, 63) .
Data processing
Data gathered from hybridization-based techniques (i.e., DNA methylation microarrays) require further processing in order to correct for scanning artifacts, background variations and its spatial distribution, batch normalization, and other issues related to GC content and CpG density (9, 64) . In addition, normalization of data obtained from arrays using competitive hybridization is also required. More often than not, the normalization techniques employed in processing DNA methylation raw array data are inspired from those used in gene expression studies (Loess and quantile normalization). However, in the case of DNA methylation, the underlying assumption that the total signal across arrays is similar may not be necessarily true, and therefore, these techniques would induce a signifi cant bias in the transformation of signal values, ultimately leading to measurement bias (9) .
Assumptions for statistical testing
Applying the correct assumptions regarding data distribution, independence of data variables, and measurement scale is a prerequisite for using the proper statistical tools. For DNA methylation data obtained from all platforms, it is necessary to mention that the data distribution is on fi nite scale (from 0 % to 100 % methylation), and this β distribution has different properties than the infi nite scale, which is used for statistical testing of gene expression data (9) . Therefore, it is argued that, rather than using statistical testing inspired from gene expression data analysis (which assumes a normal distribution, independence of variables, and values on an infi nite scale), DNA methylation data should benefi t from the application of clustering and partitioning techniques (65) .
Bioinformatics
Analyzing epigenomic data is essential for understanding the role of DNA methylation at genome-wide level. As discussed elsewhere, although many bioinformatic tools perform similarly, the advent of next generation sequencing still requires better assistance for larger-scale integrative analysis of epigenomic data sets (66) . Moreover, genome-wide epigenetic studies would benefi t from the standardization of computational methods to process and display epigenomic data sets, which would allow unbiased comparisons between experiments performed by different research teams (66) .
Data interpretation and assigning functional signifi cance are the last steps in any study assessment. In the case of dietinduced DNA methylation changes, several aspects should be carefully considered. One of them is whether, for a given intervention, the response is bimodal or not (responders vs. nonresponders) and whether this response is dependent upon the initial epigenetic status. The case of stochastic epigenetic distribution and response in the agouti model is such an example (44, 53, 67) . In the case of a bimodal response, two scenarios have to be tested in order to determine how a dietary intervention alters the epigenome. The fi rst scenario involves the existence of a bimodal epigenetic status before intervention, which could obviously be responsible for the bimodal response. The second scenario involves a homogenous epigenetic distribution at the beginning of the study, which nevertheless leads to a bimodal response. In both cases, the proper answers can be found only if the initial epigenetic status of subjects or animals tested is explored, before the start of intervention. Equally important, knowing the initial epigenetic status will prevent the bias than could occur due to randomization errors in group assignment (isogenic animal models).
Another element to consider is the epigenetic alterations induced by physiological aging, in the absence of dietary treatment (4) . It is conceivable that, among the multitude of such age-dependent changes, some of them would be responsive to the dietary treatment, while some others are not. Among the epigenetic changes that would respond to the treatment, it is important to consider that some of them could be minimized or even nullifi ed under the infl uence of a dietary exposure (for example, a diet which would delay the epigenetic response in aging). In such a case, a cross-sectional experimental design at the end of treatment would not be able to differentiate, among the identifi ed changes, which ones are due to the treatment only and which age-dependent changes were minimized by the dietary treatment (in the treated group when compared to the control). The consequence of this lack of information could be important for the identifi cation of functional importance of a given intervention and its potential for epigenetic modifi cations. Again, a longitudinal study design, in which the epigenetic status was monitored from the beginning, would respond to this question.
Another issue relates to the biological signifi cance of epigenetic changes identifi ed in proxy tissues as opposed to those in the relevant metabolically active sites. Because of obvious ethical reasons, human studies use blood DNA as a proxy tissue, when bioptic or postmortem samples are not available. Setting aside the issue of tissue homogeneity discussed above, it is arguable whether the epigenetic changes reported in blood are relevant for the metabolically active tissues in which the genes addressed are expressed. While proxy tissues are obviously valuable to establishing epigenetic markers to exposure, the functional importance of the changes has still to be explored in the relevant tissue or organ.
Expert opinion
The obvious progress in nutritional epigenetics during past two decades has brought unprecedented understanding of the intimate mechanisms that mediate nutrient-gene interactions and transgenerational inheritance of acquired traits. This progress has been accompanied by an even more accelerated development of DNA methylation assay platforms, culminating today with high-throughput sequencing. Still, important challenges exist at any level, from experimental design to the fi nal data interpretation and assigning functional value to the measured outcomes. Issues like raw data processing, statistical analysis, and bioinformatic integration have to be carefully considered. In addition, the deeper understanding of genomic variability at individual level unraveled the potential bias in measuring DNA methylation in the context of genetic mutations and copy number variations. Based on the latest progress, we speculate that such issues are not only solvable but that scientifi c community is well aware of and largely prepared to solving these issues. Therefore, the road to developing new and adequate methodologies for properly measuring and processing DNA methylation data is open and busy.
Outlook
Considering the rapid progress in understanding the epigenetic implications in gene-nutrient interactions, along with the equally rapid development of methods, we speculate that during the next decade:
Better and more comprehensive designs will be applied to -nutritional studies with epigenetic components. The cost of high-throughput methods will decrease sharply, -allowing for more complex and genome-wide approaches. Specifi c statistical methods will be developed and applied -on a wider scale, which will respond to the requirements for particular types of data structure discussed above. Methods will be developed to minimize the bias introduced -by genomic variations.
Highlights
The fi eld of nutritional epigenetics develops rapidly.
• An increasing number of nutrients and diet types are used • to unravel the epigenetic outcomes associated with nutrient intakes. Consideration should be given to issues that could generate • measurement errors or biased results at any level (design, epigenetic heterogeneity, genomic variability, quality of samples, adequate selection of detection platforms, statistical and bioinformatic analysis, and interpretation of results). Aside from his published research, Dr. Niculescu has published fi ve chapters related to nutrition and epigenetics, has edited one book, and is regularly invited to national and international scientifi c meetings. He serves on the editorial boards of several journals, is editor in chief for a journal, peer reviewer for submitted manuscript for over 13 journals, and is a grant reviewer for the NIH (USA), MRC and BBSRC (UK), and KAUST University (Saudi Arabia).
